Byoung Guk Kim
Food and Drug Administration
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Byoung Guk Kim.
Lab Animal | 2008
Sun Bo Shim; Se Hyun Lee; Chuel Kyu Kim; Byoung Guk Kim; Yong Kyu Kim; Seung Wan Jee; Su Hae Lee; Ji Soon Sin; Chang Joon Bae; Byoung Chun Lee; Mee Kyung Jang; Jung Sik Cho; Kab Ryong Chae; Dae Youn Hwang
Transportation can cause stress to laboratory animals and alter physiological characteristics that may confound experimental results. The authors investigated stress-related effects of 3–4 h of transportation by truck in two strains of mice (C57BL/6, which are known to be aggressive, and ICR, which are less aggressive). Transported mice had sufficient space and access to water, though temperature in the truck was lower than what is usually recommended. Transportation affected the following parameters in both strains of mice: (i) serum corticosterone concentrations, (ii) expression of the chaperone proteins Hsp70 and Grp78 in various tissues and (iii) concentrations of serological enzymes that are associated with liver disease. These parameters also differed substantially between the two strains of mice.
Vaccine | 2013
Hokyung Oh; Byoung Guk Kim; Kyung Tak Nam; Seung Hwa Hong; Dong Ho Ahn; Gi Sub Choi; Hyungjin Kim; Jin Tae Hong; Byung Yoon Ahn
Pertussis toxin (PTx) is an essential component of the acellular pertussis (aP) vaccine. However, because PTx in its native form is considered too toxic for human vaccine use, it must be inactivated into a stable, nontoxic form by treatment with chemical detoxifying agents or by genetic modification. Therefore, testing for the residual PTx in the aP vaccine is a major quality control step for vaccine manufacturers and regulatory authorities. The histamine sensitization test is currently the standard safety test method for all aP vaccines, regardless of the vaccine formula or the detoxification process, except for those with genetically modified PTx. However, test result variability and ethical concerns regarding animal use necessitate an alternative method. In vitro assays based on the biochemical properties of PTx have been considered as potential alternatives to the histamine sensitization test. In this study, the suitability of assays based on the ADP-ribosyltransferase and carbohydrate binding activities of PTx was assessed for PTx after treatment with formaldehyde, glutaraldehyde or both denaturants in sequence. The results indicated a distinctive pattern of the biochemical activities depending on the detoxification methods and storage conditions. These results suggest that although a more careful study is needed, these in vitro biochemical assays can be considered potential alternatives to the histamine sensitization test, as they might provide more specific safety information of aP vaccines.
Vaccine | 2012
Hokyung Oh; Jeewon Joung; Byoung Guk Kim; Kyung Tak Nam; Seung Hwa Hong; Hyun Chul Song; Ha Lim Lee; Byung Yoon Ahn
The histamine sensitization test is a widely used method for measuring the residual toxicity of pertussis toxin in acellular pertussis vaccines. Although it has been used as a routine assay for decades, the current protocols are difficult to standardize because the test results vary considerably and are based on several factors, including mouse strain, age and sex. In this study, we observed that mice of strains CD1, ddY and C57/BL6 were sufficiently sensitive to pertussis toxin among six mice strains tested and that aged male mice were more sensitive to pertussis toxin than younger or female mice. Using this animal model, we showed pertussis toxin dose-dependent responses in the two histamine sensitization test protocols based on either lethal end-point determination or mouse rectal temperature measurement. Sensitivity to pertussis toxin was further enhanced by the addition of lipopolysaccharide in both methods. With these improvements, pertussis toxin activity can be estimated more accurately and reproducibly using a reduced number of animals.
International Journal of Toxicology | 2007
Dae Y. Hwang; Kab Ryong Chae; Chuel K. Kim; Byoung Guk Kim; Sun B. Shim; Seung Wan Jee; Su H. Lee; Ji S. Sin; Mee K. Jang; Su J. Seo; Min S. Kim; Jung S. Cho; Yhun Yhong Sheen; Soo Y. Choi; Yong K. Kim
Humanized transgenic mice coexpressing tetracycline-controlled transactivator (tTA) and human cytochrome P450 1B1 (CYP1B1) (hCYP1B1) have been created by this group. The aims of this study was to determine if 7,12-dimethylbenz[a]anthracene (DMBA) functions as testosterone or doxycycline in its ability to induce or reduce expression of hCYP1B1 or endogenous mouse CYP1B1 (mCYP1B1). This was tested in the livers by treating castrated transgenic males and hCYP1B1/luciferase-transfected cells with DMBA. Herein, DMBA-treated group exhibited (i) gradual reduction of hCYP1B1 expression at the transcript, protein, and activity levels but gradually induced its transcript level during DMBA release; (ii) gradual reduction of hCYP1B1 at the transcript and protein levels, as in the case of doxycycline or testosterone; (iii) gradual induction of mCYP1B1 expression at the transcript and protein levels but gradually reduced its transcript level during DMBA release. In parallel, DMBA-treated transfected cells exhibited gradual increase in luciferase activity in a time- and dose-dependent manner. Thus, castrated transgenic males or in vitro system could be useful as models for the detection of polycyclic aromatic hydrocarbons (PAHs) or environmental toxicants by measuring either hCYP1B1 or mCYP1B1 expressions.
Journal of Virological Methods | 2006
Bok Soon Min; Yoon Ju Noh; Jin Ho Shin; Sun Young Baek; Kyung Il Min; Seung Rel Ryu; Byoung Guk Kim; Mi Kyung Park; Seung Eun Choi; Eun Hee Yang; Sue Nie Park; Sook Jin Hur; Byung Yoon Ahn
International Journal of Molecular Medicine | 2008
Dae Youn Hwang; Ji Soon Sin; Min Sun Kim; Su Youn Yim; Yong Kyu Kim; Chuel Kyu Kim; Byoung Guk Kim; Sun Bo Shim; Seung Wan Jee; Su Hae Lee; Chang Joon Bae; Byoung Chun Lee; Mee Kyung Jang; Jung Sik Cho; Kab Ryong Chae
Neurochemical Research | 2008
Sun B. Shim; Se H. Lee; Kab Ryong Chae; Chuel K. Kim; Dae Y. Hwang; Byoung Guk Kim; Seung Wan Jee; Su H. Lee; Ji S. Sin; Chang J. Bae; Byoung Chun Lee; Hyung Hoan Lee; Yong K. Kim
International Journal of Molecular Medicine | 2010
Jong-Min Woo; So Jung Park; Ho il Kang; Byoung Guk Kim; Sun Bo Shim; Seung Wan Jee; Su Hae Lee; Ji Soon Sin; Chang Joon Bae; Mee Kyung Jang; Chunghee Cho; Dae Youn Hwang; Chuel Kyu Kim
Laboratory Animal Research | 2009
Sun Bo Shim; Jong Kun Seo; Mee Kyung Jang; Seung Wan Jee; Su Hae Lee; Chang Jun Bae; Jin-Ho Kang; Jong-Min Woo; Ho il Kang; Byoung Guk Kim; Jung Sik Cho; Chuel Kyu Kim
Laboratory Animal Research | 2008
Chang Joon Bae; Min Sun Kim; Su Youn Yim; Dae Youn Hwang; Cheul kyu Kim; Byoung Guk Kim; Sun Bo Shim; Seung Wan Jee; Su Hae Lee; Ji Soon Sin; Byoung Chun Lee; Jong Min Woo; Mee Kyung Jang; Kab Ryong Chae